Delivery Order SPE2DB20D1110-SPE2DB25FK45A
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $42,178.80. This firm fixed-price delivery order, which is set to be completed by July 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Eliquis 5 mg tablets (60-count units) at a firm fixed price ceiling value of $25,069.77. This non-set-aside, competitively awarded contract is scheduled for completion by August 15, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 1, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) valued at $2,635.82. This competitively awarded, firm fixed-price delivery order is scheduled for completion by May 2, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units. This non-competitive, firm fixed-price delivery order carries a ceiling value of $11,411.02 and is scheduled for completion by September 23, 2025. The award represents a fulfillment under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a ceiling value of $16,480.94. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by September 9, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a contract ceiling value of $9,322.00. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a contract ceiling value of $26,755.38. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The place of performance is listed as AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September 10,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $11,416.41. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999.00 through December 2026. The work is to be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $11,179.57 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on September 11, 2025, with an ultimate completion date of September 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) with a contract value of $1,648.72. This firm fixed-price delivery order is set to conclude on September 18, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The order will be fulfilled from the contractor's Conshohocken, Pennsylvania facility, where AmerisourceBergen...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK45ADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Eliquis 5 mg tablets (60-count) with a ceiling value of $5,416.97. This firm fixed-price delivery order, with an ultimate completion date of September 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant prime IDC valued at $999,999,999.00 with DLA Troop Support Medical through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of medications and medical supplies to support military healthcare programs and other federal customers, including the Defense Health Agency and U.S. Coast Guard. The current delivery order for Eliquis, an anticoagulant medication, exemplifies the company's role in supplying brand-name pharmaceutical products through the DLA's medical supply chain to support federal healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 9/24/25 |